Panna Sharma

Chief Executive Officer & President Lantern Pharma

Thursday 19th February 2026

AI-Enabled Drug Discovery & Development for Glioblastoma

10:30 am

Discussing how artificial intelligence is being used to analyze complex genomic, proteomic, and clinical data to identify novel drug targets and accelerate the discovery of new therapies for glioblastoma
Optimizing clinical trial design and patient stratification, helping to identify the right patients for specific treatments and accelerate the path to regulatory approval
Highlighting how machine learning models are being developed to predict individual patient response to different therapies, enabling personalized treatment strategies and improving outcomes in this difficult-to-treat cancer